VERVE-201

· Verve Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VERVE-201, covering 2025-11-28 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia [Phase 1]